![]() |
Autoimmune Disorders |
Free Subscription
1 Am J Kidney Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Patients' Perspectives on Living With Primary Membranous Nephropathy: A
Semi-Structured Interview Study.
Am J Kidney Dis. 2025 Jun 17:S0272-6386(25)00908.
PubMed
Abstract available
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord
Pseudoatrophy in Newly Diagnosed Multiple Sclerosis.
Ann Neurol. 2025 Jun 24. doi: 10.1002/ana.27298.
PubMed
Abstract available
Chimeric antigen receptor T cell therapy for autoimmune diseases.
Curr Opin Immunol. 2025;95:102596.
PubMed
Abstract available
Sex hormones and epigenetic dysregulation in autoimmune disease.
Curr Opin Immunol. 2025;95:102595.
PubMed
Abstract available
Advances in Cell Replacement Therapies for Diabetes.
Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
PubMed
Abstract available
Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human
Islet Research Network (HIRN) Initiative.
Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
PubMed
Abstract available
The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative
to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type
1 Versus Type 2 Diabetes.
Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
PubMed
Abstract available
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on
Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096.
PubMed
Abstract available
Continuously High Titers of Multiple Islet-associated Autoantibodies in an
Individual with an Elderly Onset of Type 1 Diabetes Mellitus and Basedow's
Disease: A Case Report with a Review of Literature.
Intern Med. 2025 Jun 26. doi: 10.2169/internalmedicine.5567.
PubMed
Abstract available
Post-translationally modified proteins bind and activate complement with
implications for cellular uptake and autoantibody formation.
J Autoimmun. 2025;155:103444.
PubMed
Abstract available
Association between autoimmune diseases and glucagon-like peptide-1 receptor
agonists: A real-world evidence study.
J Autoimmun. 2025;155:103453.
PubMed
Abstract available
Serum levels of tumor necrosis factor and TNFRSF1A gene polymorphisms in Egyptian
multiple sclerosis patients: the influence on susceptibility and severity.
J Neuroimmunol. 2025;406:578672.
PubMed
Abstract available
A rare neuroendocrine presentation in pediatric anti-glutamic acid decarboxylase
autoimmunity: Case report and literature review.
J Neuroimmunol. 2025;406:578670.
PubMed
Abstract available
Therapeutic potential of S-nitrosoglutathione reductase inhibitor in B
cell-driven experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2025;406:578673.
PubMed
Abstract available
Association of TGFB1 and IFNB1 expression levels in peripheral blood mononuclear
cells with multiple sclerosis with respect to proximal rs1800469 and rs2275888
eQTLs.
J Neuroimmunol. 2025;406:578666.
PubMed
Abstract available
A multi-domain lifestyle intervention in multiple sclerosis: a longitudinal
observational study.
J Neurol. 2025;272:476.
PubMed
Abstract available
Corrigendum to "Prevalence and Clinical Significance of Autoantibodies in
Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease" [The
Journal of Pediatrics volume 239 (2021) P155 - 160].
J Pediatr. 2025 Jun 25:114677. doi: 10.1016/j.jpeds.2025.114677.
PubMed
Q fever endocarditis and glomerulonephritis.
Kidney Int. 2025;108:156.
PubMed
Detection and Characterization of NELL1 Autoantibodies in NELL1 Positive
Membranous Nephropathy.
Kidney Int. 2025 Jun 18:S0085-2538(25)00481-8. doi: 10.1016/j.kint.2025.
PubMed
Abstract available
AFRICTRIMS: a step towards broadening multiple sclerosis conversations.
Lancet Neurol. 2025;24:563-564.
PubMed
CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune
neuropathies.
Lancet Neurol. 2025;24:564-566.
PubMed
Malignant melanoma and multiple sclerosis therapies: A disproportionality
analysis of the FDA adverse event reporting system.
Mult Scler. 2025 Jun 25:13524585251342725. doi: 10.1177/13524585251342725.
PubMed
Abstract available
Multiple sclerosis mortality trends in Spain from 1981 to 2020.
Neurologia (Engl Ed). 2025 Jun 23:S2173-5808(25)00053.
PubMed
Abstract available
Optimising access to vocational rehabilitation through multiple sclerosis
charities: Protocol for a feasibility randomised controlled trial.
PLoS One. 2025;20:e0325570.
PubMed
Abstract available
Prevalence and incidence of primary autoimmune hemolytic anemia and cold
agglutinin disease in the United States, 2016-2023.
PLoS One. 2025;20:e0323843.
PubMed
Abstract available
Personalized machine learning models for noninvasive hypoglycemia detection in
people with type 1 diabetes using a smartwatch: Insights into feature importance
during waking and sleeping times.
PLoS One. 2025;20:e0325956.
PubMed
Abstract available
Intervention through an intelligent technological platform for socio-emotional
development and health promotion in adolescents with Type 1 Diabetes Mellitus
(emoTICare): A study protocol for randomized controlled trial.
PLoS One. 2025;20:e0325763.
PubMed
Abstract available
Type 1 diabetes mellitus patients had lower total vitamin K levels and increased
sensitivity to direct anticoagulants.
PLoS One. 2025;20:e0326580.
PubMed
Abstract available
Multiomics integration prioritizes potential drug targets for multiple sclerosis.
Proc Natl Acad Sci U S A. 2025;122:e2425537122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.